- Home
- HYPR vs GNTA Comparison
HYPR vs GNTA Comparison
Compare HYPR & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HYPR | GNTA |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 39.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | HYPR | GNTA |
|---|---|---|
| Price | $1.07 | $1.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.28 | N/A |
| AVG Volume (30 Days) | ★ 625.1K | 111.6K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $10,591,000.00 | N/A |
| Revenue This Year | $5.17 | N/A |
| Revenue Next Year | $35.44 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.53 | $1.35 |
| 52 Week High | $2.22 | $10.00 |
Technical Indicators
Market Signals| Indicator | HYPR | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 48.74 | 40.49 |
| Support Level | $0.85 | $1.80 |
| Resistance Level | $1.18 | $2.20 |
| Average True Range (ATR) | 0.09 | 0.24 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 68.37 | 59.77 |
Price Performance
Historical ComparisonAbout HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.